Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bristol Capital Advisors is a private investment firm that specializes in providing capital to public and private companies, with a significant focus on the life sciences, biotechnology, and healthcare sectors. The firm typically engages in structured investments, including private investments in public equity (PIPEs) and bridge financing for micro-cap and small-cap entities. Led by founder Paul Kessler, Bristol Capital Advisors aims to support emerging growth companies through various stages of development and clinical trials. Their portfolio historically includes a diverse range of medical technology and biopharmaceutical firms seeking strategic funding for expansion or research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bristol Capital Advisors.